|29.78||+0.48 / +1.64%|
As of 3:59pm ET
|29.51||-0.27 / -0.91%|
The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 34.00, with a high estimate of 45.00 and a low estimate of 26.00. The median estimate represents a +14.17% increase from the last price of 29.78.
The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.